-Symrise to distribute and commercialize Ceapro’s high-value active ingredients in the cosmetics market-
-Supply and distribution agreements give Symrise exclusive rights to some of the major international customers in the cosmetics market-
Edmonton, Alberta, March 10, 2022 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or “Company”)Is a growing biotechnology company focused on the development and commercialization of active ingredients for the healthcare and cosmetics industry, and today is the high value of Symrise AG, a German-based multinational company, and Ceapro. Announced the conclusion of a long-term contract for distribution and commercialization of. Active ingredient for major international players in the cosmetics market.
Under the contract, Symrise is guaranteed to purchase the minimum annual amount of Ceapro’s high value active ingredients. The financial terms of the contract have not been disclosed.
“Symrise has been and will continue to be a valuable and dedicated partner. We are very pleased to be able to renew this agreement with them. This agreement is currently underway. It is expected to not only provide security for the cosmeceutical-based business, but also enable it to accelerate the growth of its base business through the possibility of expanding the list of exclusive customers to Symrise. Ceapro President and Chief Executive Officer “We have a partnership with Symrise, one of the most respected players in the industry, to achieve our common goals equally,” said Gilles Gagnon, Chief Executive Officer. I am confident that we will continue to support, “he added.
“Ceapro and Symrise have a long-standing relationship in product development and have benefited both companies over the years,” said Joern Andreas, President of Symrise AG’s Cosmetic Ingredients Division. “We have found great value in this partnership and we are very pleased to have secured this agreement, which paves the way for future development, which I believe will help both companies create value. increase.”
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oat wheat and other renewable plant resources. ..
Ceapro adds additional value to the extract by supporting its use in cosmeceuticals, dietary supplements, and therapeutic products for humans and animals. The company has extensive expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills combine in the areas of active ingredients, biopharmacy and drug delivery solutions. For more information on Ceapro, please visit our website at www.ceapro.com.
Symrise is a global supplier of fragrances, flavors, foods, nutrition and cosmetic ingredients. Its customers include perfumes, cosmetics, food and beverage manufacturers, pharmaceuticals, dietary supplements and pet food manufacturers. Headquartered in Holzminden, Germany, the group is represented by more than 100 offices in Europe, Africa, the Middle East, Asia, the United States and Latin America. www.symrise.com
Neither the TSX Venture Exchange nor its regulatory service provider (the term is defined in the TSX Venture Exchange Policy) is responsible for the validity or accuracy of this release.
Investor and media contacts:
Jenene Thomas Communications, LLC
T (USA): 908-938-1475
Source: Ceapro Inc.
CBJ News Maker
Ceapro has entered into exclusive long-term supply and distribution agreements with major global providers of active ingredients, Symrise and Canadian Business Journal.
Source link Ceapro has entered into exclusive long-term supply and distribution agreements with major global providers of active ingredients, Symrise and Canadian Business Journal.